.

0 (hodnocen0 x )

BK

Bibliografie

Revised 4th edition

Lyon : International Agency for Research on Cancer, 2017

585 stran : barevné ilustrace ; 27 cm

ISBN 978-92-832-4494-3 (brožováno)

World Health Organization classification of tumours

Nad názvem: WHO, OMS, International Agency for Research on Cancer (IARC)

Obsahuje bibliografii na stranách 504-576 a rejstřík

001484789

WHO Classification of tumours of haematopoietic and lymphoid tissues 10 // Introduction to the WHO classification of tumours of haematopoietic and lymphoid tissues 13 // 1 Introduction and overview of the classification of the myeloid neoplasms 15 // 2 Myeloproliferative neoplasms 29 // Chronic myeloid leukaemia, 8CfM8M-positive 30 // Chronic neutrophilic leukaemia 37 // Polycythaemia vera 39 // Primary myelofibrosis 44 // Prefibrotic/early primary myelofibrosis 46 // Overt primary myelofibrosis 48 // Essential thrombocythaemia 50 // Chronic eosinophilic leukaemia, not otherwise specified 54 // Myeloproliferative neoplasm, unclassifiable 57 // 3 Mastocytosis 61 // Cutaneous mastocytosis 65 // Systemic mastocytosis 66 // Mast cell sarcoma 69 // 4 Myeloid/lymphoid neoplasms with eosinophilia and gene rearrangement 71 // Myeloid/lymphoid neoplasms with PDGFRA rearrangement 73 // Myeloid/lymphoid neoplasms with PDGFRB rearrangement 75 // Myeloid/lymphoid neoplasms with FGFR1 rearrangement 77 // Myeloid/lymphoid neoplasms with PCM1-JAK2 78 // 5 Myelodysplastic/myeloproliferative neoplasms 81 // Chronic myelomonocytic leukaemia 82 // Atypical chronic myeloid leukaemia, BCR-ABU-negaWve 87 // Juvenile myelomonocytic leukaemia 89 // Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis 93 // Myelodysplastic/myeloproliferative neoplasm, unclassifiable 95 // 6 Myelodysplastic syndromes 97 // Overview 98 // Myelodysplastic syndrome with single lineage dysplasia 106 // Myelodysplastic syndrome with ring sideroblasts 109 // Myelodysplastic syndrome with multilineage dysplasia 111 // Myelodysplastic syndrome with excess blasts 113 // Myelodysplastic syndrome with excess blasts and erythroid predominance 114 // Myelodysplastic syndrome with excess blasts and fibrosis 114 // Myelodysplastic syndrome with isolated del(5q) 115 //

Myelodysplastic syndrome, unclassifiable 116 // Childhood myelodysplastic syndrome 116 // Refractory cytopenia of childhood 117 // 7 Myeloid neoplasms with germline predisposition 121 // Myeloid neoplasms with germline predisposition without a pre-existing disorder or organ dysfunction 124 // Acute myeloid leukaemia with germline ??? mutation 124 // Myeloid neoplasms with germline DDX41 mutation 125 // Myeloid neoplasms with germline predisposition and pre-existing platelet disorders 125 // Myeloid neoplasms with germline RUNX1 mutation 125 // Myeloid neoplasms with germline ANKRD26 mutation 125 // Myeloid neoplasms with germline ETV6 mutation 126 // Myeloid neoplasms with germline predisposition associated with other organ dysfunction 126 // Myeloid neoplasms with germline GA7A2 mutation 126 // Myeloid neoplasms with germline predisposition associated with inherited bone failure syndromes and telomere biology disorders 128 // 8 Acute myeloid leukaemia and related precursor neoplasms 129 // Acute myeloid leukaemia with recurrent genetic abnormalities 130 // Introduction 130 // Acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 130 // Acute myeloid leukaemia with inv(16)(p13.1q22) or t(16;16)(p13.1 ;q22); CBFB-MYH11 132 // Acute promyelocytic leukaemia with PML-RARA 134 // Acute myeloid leukaemia with t(9; 11 )(p21.3;q23.3); KMT2A-MLLT3 136 // Acute myeloid leukaemia with t(6;9)(p23;q34.1); DEK-NUP214 137 // Acute myeloid leukaemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM 138 // Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 139 // Acute myeloid leukaemia with BCR-ABL1 140 // Acute myeloid leukaemia with gene mutations 141 // Acute myeloid leukaemia with mutated NPM1 141 // Acute myeloid leukaemia with biallelic mutation of ??? 142 // Acute myeloid leukaemia with mutated RUNX1 144 //

Acute myeloid leukaemia with myelodysplasia-related changes 150 // Therapy-related myeloid neoplasms 153 // Acute myeloid leukaemia, not otherwise specified 156 // Acute myeloid leukaemia with minimal differentiation 156 // Acute myeloid leukaemia without maturation 157 // Acute myeloid leukaemia with maturation 158 // Acute myelomonocytic leukaemia 159 // Acute monoblastic and monocytic leukaemia 160 // Pure erythroid leukaemia 161 // Acute megakaryoblastic leukaemia 162 // Acute basophilic leukaemia 164 // Acute panmyelosis with myelofibrosis 165 // Myeloid sarcoma 167 // Myeloid proliferations associated with Down syndrome // Transient abnormal myelopoiesis associated with Down syndrome // Myeloid leukaemia associated with Down syndrome // 9 Blastic plasmacytoid dendritic cell neoplasm // 10 Acute leukaemias of ambiguous lineage // Acute undifferentiated leukaemia // Mixed-phenotype acute leukaemia with t(9;22)(q34.1 ;q11.2); BCR-ABL1 // Mixed-phenotype acute leukaemia with t(v;11q23.3); K/WT2A-rear ranged // Mixed-phenotype acute leukaemia, B/myeloid, not otherwise specified // Mixed-phenotype acute leukaemia, T/myeloid, not otherwise specified // Mixed-phenotype acute leukaemia, not otherwise specified, rare types // Acute leukaemias of ambiguous lineage, not otherwise specified // 11 Introduction and overview of the classification of the lymphoid neoplasms // 12 Precursor lymphoid neoplasms // B-lymphoblastic leukaemia/lymphoma, not otherwise specified // B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities // B-lymphoblastic leukaemia/lymphoma with t(9;22)(q34.1 ;q11.2); BCR-ABL 1 // B-lymphoblastic leukaemia/lymphoma with t(v;11q23.3); K7W72A-rearranged // B-lymphoblastic leukaemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 // B-lymphoblastic leukaemia/lymphoma with hyperdiploidy //

B-lymphoblastic leukaemia/lymphoma with hypodiploidy / B-lymphoblastic leukaemia/lymphoma with t(5;14)(q31.1 ;q32.1); IGH//L3 // B-lymphoblastic leukaemia/lymphoma with t(1 ;19)(q23;p13.3); TCF3-PBX1 // B-lymphoblastic leukaemia/lymphoma, BCR-ABL1-\\\ke // B-lymphoblastic leukaemia/lymphoma with ÍAMP21 // T-lymphoblastic leukaemia/lymphoma // Early T-cell precursor lymphoblastic leukaemia NK-lymphoblastic leukaemia/lymphoma // 13 Mature ?-cell neoplasms // Chronic lymphocytic leukaemia/ small lymphocytic lymphoma Monoclonal ?-cell lymphocytosis ?-cell prolymphocytic leukaemia Splenic marginal zone lymphoma Hairy cell leukaemia // Splenic ?-cell lymphoma/leukaemia, unclassifiable // Splenic diffuse red pulp small ?-cell lymphoma /// airy cell leukaemia variant Lymphoplasmacytic lymphoma // IgM Monoclonal gammopathy of undetermined significance // Heavy chain diseases Mu heavy chain disease Gamma heavy chain disease Alpha heavy chain disease Plasma cell neoplasms // Non-IgM monoclonal gammopathy of undetermined significance // Plasma cell myeloma // Plasma cell myeloma variants // Smouldering (asymptomatic) plasma cell myeloma // Non-secretory myeloma Plasma cell leukaemia Plasmacytoma // Solitary plasmacytoma of bone Extraosseous plasmacytoma Monoclonal immunoglobulin deposition diseases Primary amyloidosis // Light chain and heavy chain deposition diseases // Plasma cell neoplasms with associated paraneoplastic syndrome POEMS syndrome TEMPI syndrome // Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) // Nodal marginal zone lymphoma // Paediatric nodal marginal zone lymphoma Follicular lymphoma // Testicular follicular lymphoma // In situ follicular neoplasia // Duodenal-type follicular lymphoma // Paediatric-type follicular lymphoma Large ?-cell lymphoma with IRF4 rearrangement // Primary cutaneous follicle centre lymphoma //

Mantle cell lymphoma // Leukaemic non-nodal mantle

cell lymphoma // In situ mantle cell neoplasia Diffuse large ?-cell lymphoma (DLBCL), NOS T-cell/histiocyte-rich large ?-cell lymphoma // Primary diffuse large ?-cell lymphoma of the CNS // Primary cutaneous diffuse large ?-cell lymphoma, leg type EBV-positive diffuse large ?-cell lymphoma, NOS EBV-positive mucocutaneous ulcer // Diffuse large ?-cell lymphoma associated with chronic inflammation // Fibrin-associated diffuse large ?-cell lymphoma // Lymphomatoid granulomatosis // Primary mediastinal (thymic) large ?-cell lymphoma // Intravascular large ?-cell lymphoma // ALK-positive large ?-cell lymphoma // Plasmablastic lymphoma // Primary effusion lymphoma // HHV8-associated lymphoproliferative disorders // Multicentric Castleman disease // HHV8-positive diffuse large ?-cell lymphoma, NOS HHV8-positive germinotropic lymphoproliferative disorder // Burkitt lymphoma // Burkitt-like lymphoma with 11q aberration // High-grade ?-cell lymphoma // High-grade ?-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements High-grade ?-cell lymphoma, NOS // 169 // 169 // 170 // 173 // 179 // 182 // 182 // 183 // 184 // 185 // 186 // 187 // 189 // 199 // 200 // 203 // 203 // 203 // 204 // 205 // 206 // 206 // 207 // 208 // 208 // 209 // 212 // 213 // 215 // 216 // 220 // 222 // 223 // 226 // 229 // 229 // 230 // 232 // 236 // ?-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma 342 // 14 Mature T- and NK-cell neoplasms // T-cell prolymphocytic leukaemia T-cell large granular lymphocytic

leukaemia Chronic lymphoproliferative disorder of NK cells Aggressive NK-cell leukaemia EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood // Systemic EBV+ T-cell lymphoma of childhood Chronic active EBV infection of T- and NK-cell type, systemic form Hydroa vacciniforme-like lymphoproliferative disorder Severe mosquito bite allergy Adult T-cell leukaemia/lymphoma Extranodal NK/T-cell lymphoma, nasal type Intestinal T-cell lymphoma // Enteropathy-associated T-cell lymphoma Monomorphic epitheliotropic intestinal T-cell lymphoma Intestinal T-cell lymphoma, NOS Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract Hepatosplenic T-cell lymphoma Subcutaneous panniculitis-like T-cell lymphoma Mycosis fungoides Sézary syndrome // Primary cutaneous CD30-positive T-cell lymphoproliferative disorders Lymphomatoid papulosis // Primary cutaneous anaplastic large cell lymphoma Primary cutaneous peripheral T-cell lymphomas, rare subtypes Introduction // Primary cutaneous gamma delta T-cell lymphoma Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Primary cutaneous acral CD8-positive T-cell lymphoma Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder Peripheral T-cell lymphoma, NOS Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper (TEH) cell origin Angioimmunoblastic T-cell lymphoma Follicular T-cell lymphoma Nodal peripheral T-cell lymphoma with TEH phenotype

// Anaplastic large cell lymphoma, ALK-positive // Anaplastic large cell lymphoma, ALK-negative // Breast implant-associated anaplastic large cell lymphoma // 345 // 346 348 351 353 // 355 // 355 // 358 // 360 // 362 // 363 368 372 372 // 377 // 378 // 379 381 383 385 390 // 392 // 392 // 395 // 397 // 397 // 397 // 399 // 400 // 401 403 // 407 // 408 // 411 // 412 // 413 418 421 // 15 Hodgkin lymphomas 42d // Introduction 424 // Nodular lymphocyte predominant Hodgkin lymphoma 431 // Classic Hodgkin lymphoma 435 // Nodular sclerosis classic Hodgkin lymphoma 435 // Lymphocyte-rich classic Hodgkin lymphoma 438 // Mixed-cellularity classic Hodgkin lymphoma 440 // Lymphocyte depleted classic Hodgkin lymphoma 441 // 16 Immunodeficiency-associated lymphoproliferative disorders // Lymphoproliferative diseases associated with primary // immune disorders 444 // Lymphomas associated with HIV infection 449 // Post-transplant lymphoproliferative disorders (PTLD) 453 // Non-destructive PTLD 456 // Polymorphic PTLD 457 // Monomorphic PTLD (B- and T/NK-cell types) 459 // Monomorphic ?-cell PTLD 459 // Monomorphic T/NK-cell PTLD 461 // Classic Hodgkin lymphoma PTLD 462 // Other iatrogenic immunodeficiency-associated // lymphoproliferative disorders 462 // 17 Histiocytic and dendritic cell neoplasms // Introduction Histiocytic sarcoma // Tumours derived from Langerhans cells Langerhans cell histiocytosis Langerhans cell sarcoma Indeterminate dendritic cell tumour Interdigitating dendritic cell

sarcoma Follicular dendritic cell sarcoma // Inflammatory pseudotumour-like follicular/fibroblastic dendritic cell sarcoma Fibroblastic reticular cell tumour Disseminated juvenile xanthogranuloma Erdheim-Chester disease // 465 // 466 468 470 470 // 473 // 474 // 475 // 476 // 478 // 479 // 480 // 481 // Contributors // Declaration of interests // Clinical Advisory Committees // IARC/WHO Commitee for ICD-0 // Sources of figures and tables // References // Subject index // List of abbreviations // 484 // 493 // 494 // 496 // 497 504 577 586